LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

CUSIP: N51517105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common shares, Euro 0.12 nominal value per share
Shares outstanding
26,019,256
Total 13F shares
9,222,819
Share change
+9,222,819
Total reported value
$139,085,000
Price per share
$15.19
Number of holders
24
Value change
+$139,085,000
Number of buys
24

Quarterly Holders Quick Answers

What is CUSIP N51517105?
CUSIP N51517105 identifies LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) as of Q1 2021

As of 31 Mar 2021, LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,222,819 shares. The largest 10 holders included Novo Holdings A/S, Redmile Group, LLC, Nicholas Investment Partners, LP, Nantahala Capital Management, LLC, Monashee Investment Management LLC, MILLENNIUM MANAGEMENT LLC, AXA S.A., SPHERA FUNDS MANAGEMENT LTD., Artal Group S.A., and Falcon Edge Capital, LP. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q3 2025 Across Filers

Q3 2025 holders
21
Q1 2021 holders
24
Holder diff
3
Investor Q3 2025 Shares Q1 2021 Shares Share Diff Share Chg % Q3 2025 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .